NCT03910348

Brief Summary

We investigated the effects of whole body vibration (WBV) and high-impact (HI) exercises in postmenopausal women with low bone mineral density. In summary, WBV exercises are effective in preventing bone loss and WBV and HI exercise programs are effective in decreasing fall risk, increasing health-related quality of life and improving depressive symptoms

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
7.6 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 10, 2019

Completed
Last Updated

April 10, 2019

Status Verified

April 1, 2019

Enrollment Period

1.3 years

First QC Date

April 8, 2019

Last Update Submit

April 9, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from Baseline Bone Mineral Density at 6 months

    The bone mineral density of the lumbar spine, femoral neck were measured with a dual energy x-ray absorptiometry

    baseline and 6 month

Secondary Outcomes (6)

  • Change from Baseline Bone Formation Marker at 3-months and 6-months

    baseline, 3-month, 6-month

  • Change from Baseline Bone Resorption Marker- at 3-months and 6-months

    baseline, 3-month, 6-month

  • Change from Baseline Fall risk at 3-months and 6-months

    baseline, 3-month, 6-month

  • Change from Baseline Functional Balance at 3-months and 6-months

    baseline, 3-month, 6-month

  • Change from Baseline Health-related Quality of Life at 6 months

    baseline, 6-month

  • +1 more secondary outcomes

Study Arms (3)

Whole body vibration exercise

EXPERIMENTAL

The WBV training consisted of a high frequency (30-40 Hz) vibration stimulus at a low setting (2-4mm peak to peak) on a Power Plate pro5 vibration platform (Performance Health Systems, LLC, Northbrook, IL, USA). Each patient received the vibrations under supervision using five different static positions: squat, deep squat, widestep squat, lunge, and hands-front lunge. The exercise programs for each experimental groups consisted of 20 to 60-minute sessions on three days per week for 24 weeks, and they were performed under the supervision.

Device: Whole-body vibration exercise

High-impact exercise

EXPERIMENTAL

Depending on their individual calcium and vitamin D intakes, each patient advised to receive supplemental calcium and vitamin D to ensure a total daily intake of 1,500 mg of calcium and 880 IU of vitamin D.

Other: High-impact exercise

Control

NO INTERVENTION

Depending on their individual calcium and vitamin D intakes, each patient received supplemental calcium and vitamin D to ensure a total daily intake of 1,500 mg of calcium and 880 IU of vitamin D. The demographic characteristics of the participants were obtained at the baseline assessment.

Interventions

The WBV training consisted of a high frequency (30-40 Hz) vibration stimulus at a low setting on a Power Plate pro5 vibration platform (Performance Health Systems, LLC, Northbrook, IL, USA).

Whole body vibration exercise

In the high-impact exercise program, the patients were asked to jump using a jump-rope at the beginning of each session

High-impact exercise

Eligibility Criteria

Age40 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal women aged 40-65 years old
  • Bone mineral density T-scores between -2.0 and -3.0 at the L1-L4, L2-L4, femoral neck, trochanter and/or total hip regions
  • Serum 25(OH)vitamin D level ≥ 30 ng/ml.

You may not qualify if:

  • The use of any medications and/or disease that affect bone metabolism
  • Neuromuscular performance, and/or balance; presence of cardiovascular, pulmonary, neuromuscular, and/or chronic diseases that affect exercise training
  • Presence of an osteoporotic fracture
  • Presence of a musculoskeletal disease, such as an acute lumbar herniated disc and/or spondylolisthesis
  • Presence of gall or kidney stones, prostheses, intraocular lenses, and/or implants
  • Body mass index ≥35 kg/m²
  • Thrombosis history

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoporosis, Postmenopausal

Condition Hierarchy (Ancestors)

OsteoporosisBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Ekin I Sen

    Istanbul University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

April 8, 2019

First Posted

April 10, 2019

Study Start

January 1, 2010

Primary Completion

May 1, 2011

Study Completion

September 1, 2011

Last Updated

April 10, 2019

Record last verified: 2019-04